Systematically In Silico Comparison of Unihormonal and Bihormonal Artificial Pancreas Systems

Table 4

Statistical results for experiments on the standard subject under P-type and PD-type therapies. There are two situations: +20% means that the glucagon sensitivity is 20% higher than the nominal case; −20% means that the glucagon sensitivity is 20% lower than the nominal case.

Glucagon sensitivity	Therapies	% of BG <70 mg/dL	% of BG >180 mg/dL	BGI	SD (mg/dL)
+20%	P-type therapy	0	0	0.74	16.73
	PD-type therapy	0	0	0.56	13.72
−20%	P-type therapy	0	0	0.79	17.90
	PD-type therapy	0	0	0.56	14.71